NVIDIA
NVDA
Palantir
PLTR
Tesla
TSLA
4
Hims & Hers Health
HIMS
5
Alibaba
BABA
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Cash cash equivalents and federal funds sold | 52.48%860M | 52.48%860M | 3.14%624M | 50.33%681M | 53.05%577M | 67.36%564M | 67.36%564M | 67.13%605M | 73.56%453M | -47.20%377M |
-Cash and cash equivalents | 18.69%635M | 18.69%635M | -7.78%486M | 46.23%601M | 41.78%509M | 76.57%535M | 76.57%535M | 105.06%527M | 101.47%411M | -48.35%359M |
-Restricted cash and investments | 675.86%225M | 675.86%225M | 76.92%138M | 90.48%80M | 277.78%68M | -14.71%29M | -14.71%29M | -25.71%78M | -26.32%42M | -5.26%18M |
Receivables | 97.70%516M | 97.70%516M | 47.49%382M | 77.96%331M | 139.18%464M | 45.00%261M | 45.00%261M | 43.09%259M | -20.85%186M | 45.86%194M |
Net PPE | ---- | ---- | -46.15%7M | -46.67%8M | -50.00%9M | ---- | ---- | -38.10%13M | -34.78%15M | -25.00%18M |
Other assets | 56.44%158M | 56.44%158M | 48.25%169M | 22.22%99M | 9.33%82M | 24.69%101M | 24.69%101M | -15.56%114M | -25.00%81M | -29.25%75M |
Total assets | 18.71%28.25B | 18.71%28.25B | 18.24%27.1B | 17.37%26.09B | 11.20%24.26B | 6.26%23.8B | 6.26%23.8B | 4.00%22.92B | 1.99%22.23B | 6.59%21.81B |
Liabilities | ||||||||||
Payables | 101.16%865M | 101.16%865M | 23.38%496M | 48.47%484M | 27.27%476M | 20.79%430M | 20.79%430M | -24.86%402M | -36.94%326M | -1.58%374M |
-Accounts payable | 192.09%406M | 192.09%406M | 90.70%164M | 75.27%163M | 32.97%121M | 9.45%139M | 9.45%139M | -60.37%86M | -57.73%93M | -8.08%91M |
-Other payable | 57.73%459M | 57.73%459M | 5.06%332M | 37.77%321M | 25.44%355M | 27.07%291M | 27.07%291M | -0.63%316M | -21.55%233M | 0.71%283M |
Long term debt and capital lease obligation | 15.45%13.76B | 15.45%13.76B | 17.08%13.55B | 13.80%13.01B | 4.19%11.74B | -3.26%11.92B | -3.26%11.92B | -2.99%11.57B | -3.49%11.43B | 5.93%11.27B |
Other liabilities | 9.56%275M | 9.56%275M | 115.15%284M | 95.87%237M | 40.17%164M | 50.30%251M | 50.30%251M | -5.04%132M | 18.63%121M | 85.71%117M |
Total liabilities | 18.26%14.9B | 18.26%14.9B | 18.36%14.33B | 15.58%13.73B | 5.28%12.38B | -1.90%12.6B | -1.90%12.6B | -3.94%12.11B | -4.69%11.88B | 6.13%11.76B |
Shareholders'equity | ||||||||||
Share capital | 0.00%1M | 0.00%1M | 0.00%1M | 0.00%1M | 0.00%1M | 0.00%1M | 0.00%1M | --1M | --1M | --1M |
-common stock | 0.00%1M | 0.00%1M | 0.00%1M | 0.00%1M | 0.00%1M | 0.00%1M | 0.00%1M | --1M | --1M | --1M |
Paid-in capital | 16.43%12.5B | 16.43%12.5B | 14.65%12.04B | 14.10%11.72B | 12.14%11.25B | 12.37%10.74B | 12.37%10.74B | 12.11%10.51B | 12.41%10.27B | 10.61%10.03B |
Retained earnings | 84.42%852M | 84.42%852M | 135.60%728M | 702.50%642M | 4,033.33%620M | 23,200.00%462M | 23,200.00%462M | 368.18%309M | -59.18%80M | -95.13%15M |
Total stockholders'equity | 19.23%13.36B | 19.23%13.36B | 18.10%12.77B | 19.41%12.36B | 18.14%11.87B | 17.23%11.2B | 17.23%11.2B | 14.61%10.82B | 10.92%10.35B | 7.14%10.05B |
Total equity | 19.23%13.36B | 19.23%13.36B | 18.10%12.77B | 19.41%12.36B | 18.14%11.87B | 17.23%11.2B | 17.23%11.2B | 14.61%10.82B | 10.92%10.35B | 7.14%10.05B |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |